Christopher Young > DLA Piper LLP (US) > San Diego (Downtown), United States > Lawyer Profile

DLA Piper LLP (US)
SUITE 1700
SAN DIEGO, CA 92101-4297
United States

Work Department

Litigation, Arbitration and Investigations; Product Liability, Mass Torts and Product Stewardship; Class Actions; Intellectual Property and Technology; International Trade, Regulatory and Government Affairs; Cross-Border Litigation; Commercial Contracts Disputes; Life Sciences; Healthcare




Christopher Young is an experienced trial lawyer and litigator who concentrates his practice in the defense of consumer class action litigation, product liability and mass tort litigation, and pharmaceutical and medical device litigation. His clients include life sciences companies, product manufacturers, food and beverage companies, educational institutions, transportation companies and others.

Christopher represents clients on a local, national and global basis and has extensive experience with the use of various forms of technology to coordinate and support complex mass tort litigation.

Christopher is also a member of DLA Piper’s North America Pro Bono Committee and of the firm’s Associate Evaluation and Compensation Committee.




Defense Research Institute (DRI); Barrister, Louis M. Welsh Chapter, American Inns of Court


J.D., University of California at Berkeley; B.A., Pomona College

Lawyer Rankings

United States > Dispute resolution > Product liability, mass tort and class actions: pharmaceuticals and medical devices - defense

DLA Piper LLP (US) is headed by Raymond Williams in Philadelphia and Christopher Young in San Diego, and is one of the leading firms for high-profile product liability litigation and mass torts in the medical and pharmaceuticals sectors. Notable highlights include representing Medtronic and Covidien as co-national counsel in the hernia mesh litigation, and defending Pfizer and Wyeth Pharmaceuticals in product liability litigation, in which plaintiffs claim that long-term use of proton pump inhibitors (PPIs) cause various forms of kidney disease. In other work, the highly regarded Loren Brown in New York is acting for Pfizer alongside Boston-based Matthew Holian in an MDL involving claims that anti-coagulant medication Eliquis causes bleeding. Cara Edwards in New York is also recommended. In January 2018, the team welcomed Stephen Matthews and Amy Rubenstein from Porzio, Bromberg & Newman and Schiff Hardin LLP respectively; in February 2018, Matt Nickel and Mike Moore joined from Dentons.